XBiotech Inc
NASDAQ:XBIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
XBiotech Inc
NASDAQ:XBIT
|
US |
|
Atlantic Lithium Ltd
LSE:ALL
|
AU |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
L
|
Laramide Resources Ltd
F:L4R
|
CA |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
|
R
|
Relx PLC
F:RDED
|
UK |
|
Astra Agro Lestari Tbk PT
IDX:AALI
|
ID |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
R
|
Relx PLC
NYSE:RELX
|
UK |
|
Cuscal Ltd
F:Y49
|
AU |
|
C
|
Charles Schwab Corp
DUS:SWG
|
US |
|
E
|
Endesa SA
XMUN:ENA
|
ES |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
UniCredit SpA
F:CRIP
|
IT |
|
Klepierre SA
PAR:LI
|
FR |
|
Canyon Resources Ltd
ASX:CAY
|
AU |
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
CA |
|
M
|
Mitsubishi Estate Co Ltd
DUS:MES
|
JP |
|
Nexgen Energy Ltd
LSE:0V9D
|
CA |
|
E
|
Endesa SA
DUS:ENA
|
ES |
|
A
|
Alliant Energy Corp
F:AY1
|
US |
|
A
|
Apple Inc
XHAM:APC
|
US |
|
Max Resource Corp
OTC:MXROF
|
CA |
Bankruptcy Probability
XBiotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
XBiotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
XBiotech Inc
NASDAQ:XBIT
|
59.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
XBiotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, XBiotech Inc has no debt.
You can find a full breakdown on its Balance Sheet.